UltraTech Cement shares in focus as brokerages revise target prices after Q2 results. What Citi, Nomura, Jefferies say
60-Word AI Digest
UltraTech Cement’s Q2FY27 results prompted Nomura, Citi and Jefferies to revise their target prices for the stock. While Nomura and Citi cut their targets, Jefferies raised its estimate, with all three brokerages retaining Buy ratings. UltraTech reported a 21% year-on-year rise in quarterly profit to Rs 1,494 crore.
Key Takeaways
- UltraTech Cement’s Q2FY27 results prompted Nomura, Citi and Jefferies to revise their target prices for the stock.
- While Nomura and Citi cut their targets, Jefferies raised its estimate, with all three brokerages retaining Buy ratings.
- UltraTech reported a 21% year-on-year rise in quarterly profit to Rs 1,494 crore.
UltraTech Cement’s Q2FY27 results prompted Nomura, Citi and Jefferies to revise their target prices for the stock. While Nomura and Citi cut their targets, Jefferies raised its estimate, with all three brokerages retaining Buy ratings. UltraTech reported a 21% year-on-year rise in quarterly profit to Rs 1,494 crore.
Original Publisher Attribution
This summary was curated from Economic Times.